Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

MicroRNAs01:22

MicroRNAs

3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
MicroRNAs01:22

MicroRNAs

21.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
21.0K
MicroRNAs01:22

MicroRNAs

9.8K
9.8K
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

43.0K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
43.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A controlled-release mitochondrial protonophore attenuates early- and late-stage atheroprogression in mice.

Science translational medicine·2026
Same author

Bridging the gap from clinical to home ECG: quantifying and overcoming accuracy loss in AI-enabled single-lead ECG models.

NPJ digital medicine·2026
Same author

Deep learning analysis of 12-lead electrocardiograms for bloodstream infection prediction: a multi-center validation study.

BMC medical informatics and decision making·2026
Same author

<i>Tet2</i> and <i>Jak2</i> clonal hematopoiesis do not modify murine tauopathy.

Journal of Alzheimer's disease : JAD·2026
Same author

Context-dependent regulation of endothelial inflammation and atherosclerosis by endothelial microRNA-33.

Atherosclerosis·2026
Same author

Mutation-dependent responses to sleep and exercise in clonal haematopoiesis.

Nature·2026

Related Experiment Video

Updated: Apr 28, 2026

Fast and Simplified Method for High Through-put Isolation of miRNA from Highly Purified High Density Lipoprotein
09:48

Fast and Simplified Method for High Through-put Isolation of miRNA from Highly Purified High Density Lipoprotein

Published on: July 27, 2016

11.3K

microRNAs and HDL life cycle.

Alberto Canfrán-Duque1, Cristina M Ramírez1, Leigh Goedeke1

  • 1Vascular Biology and Therapeutics Program, Yale University School of Medicine, 10 Amistad Street, Amistad Research Building, Room 337C, New Haven 06510, CT, USA Integrative Cell Signalling and Neurobiology of Metabolism Program, Section of Comparative Medicine, Yale University School of Medicine, New Haven, CT, USA.

Cardiovascular Research
|June 5, 2014
PubMed
Summary

MicroRNAs regulate high-density lipoprotein (HDL) metabolism and cholesterol transport. Inhibiting microRNAs, like miR-33, shows potential for treating atherosclerosis and dyslipidemia.

Keywords:
ABCA1 and SRB1Cholesterol metabolismMiRNAs

More Related Videos

Enrichment of Native Lipoprotein Particles with microRNA and Subsequent Determination of Their Absolute/Relative microRNA Content and Their Cellular Transfer Rate
11:13

Enrichment of Native Lipoprotein Particles with microRNA and Subsequent Determination of Their Absolute/Relative microRNA Content and Their Cellular Transfer Rate

Published on: May 9, 2019

10.9K
In Vivo Nanovector Delivery of a Heart-specific MicroRNA-sponge
09:53

In Vivo Nanovector Delivery of a Heart-specific MicroRNA-sponge

Published on: June 15, 2018

7.2K

Related Experiment Videos

Last Updated: Apr 28, 2026

Fast and Simplified Method for High Through-put Isolation of miRNA from Highly Purified High Density Lipoprotein
09:48

Fast and Simplified Method for High Through-put Isolation of miRNA from Highly Purified High Density Lipoprotein

Published on: July 27, 2016

11.3K
Enrichment of Native Lipoprotein Particles with microRNA and Subsequent Determination of Their Absolute/Relative microRNA Content and Their Cellular Transfer Rate
11:13

Enrichment of Native Lipoprotein Particles with microRNA and Subsequent Determination of Their Absolute/Relative microRNA Content and Their Cellular Transfer Rate

Published on: May 9, 2019

10.9K
In Vivo Nanovector Delivery of a Heart-specific MicroRNA-sponge
09:53

In Vivo Nanovector Delivery of a Heart-specific MicroRNA-sponge

Published on: June 15, 2018

7.2K

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cardiovascular Research

Background:

  • MicroRNAs (miRNAs) are key regulators of gene expression.
  • Lipoprotein metabolism, particularly high-density lipoprotein (HDL) metabolism, is intricately controlled by various genetic factors.
  • Dysregulation of HDL metabolism is linked to cardiovascular diseases, including atherosclerosis.

Purpose of the Study:

  • To review the role of miRNAs in regulating HDL metabolism.
  • To explore the therapeutic potential of targeting miRNAs for cardiometabolic diseases.
  • To discuss how miRNA manipulation impacts reverse cholesterol transport.

Main Methods:

  • Review of existing literature on miRNAs and lipoprotein metabolism.
  • Analysis of studies investigating miRNA involvement in HDL biogenesis and cholesterol efflux.
  • Examination of animal model data on miRNA manipulation and its effects on HDL-C levels and atherosclerosis.

Main Results:

  • miRNAs control key genes in HDL metabolism, such as ABCA1, ABCG1, and SRB1.
  • miRNA regulation influences HDL biogenesis, cellular cholesterol efflux, and hepatic HDL cholesterol uptake.
  • In vivo studies show that antagonizing miR-33 increases HDL-C and reduces atherosclerosis progression.

Conclusions:

  • miRNAs are critical regulators of the entire reverse cholesterol transport pathway.
  • Targeting specific miRNAs, such as miR-33, represents a promising therapeutic strategy for dyslipidemia and atherosclerosis.
  • miRNA inhibitors offer a potential new avenue for treating cardiometabolic diseases.